Benefit of prompt initiation of single-inhaler triple therapy in COPD patients in England following an exacerbation

A. Ismaila (Collegeville, United States), R. Wood (Bollington, United Kingdom), A. Czira (Brentford, United Kingdom), V. Banks (Bollington, United Kingdom), L. Camidge (Bollington, United Kingdom), O. Massey (Bollington, United Kingdom), R. Sharma (Brentford, United Kingdom), C. Compton (Brentford, United Kingdom), K. Rothnie (Brentford, United Kingdom)

Source: International Congress 2022 – COPD treatment: new mechanisms and novel insights
Session: COPD treatment: new mechanisms and novel insights
Session type: Oral Presentation
Number: 747

Congress or journal article abstractWebcastPDF journal article, handout or slidesE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Ismaila (Collegeville, United States), R. Wood (Bollington, United Kingdom), A. Czira (Brentford, United Kingdom), V. Banks (Bollington, United Kingdom), L. Camidge (Bollington, United Kingdom), O. Massey (Bollington, United Kingdom), R. Sharma (Brentford, United Kingdom), C. Compton (Brentford, United Kingdom), K. Rothnie (Brentford, United Kingdom). Benefit of prompt initiation of single-inhaler triple therapy in COPD patients in England following an exacerbation. 747

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.